PHILADELPHIA, May 8, 2023 /PRNewswire/ -- Carisma Therapeutics Inc. (Nasdaq:CARM) ("Carisma" or the "Company"), a clinical-stage biopharmaceutical company focused on discovering and developing innovative immunotherapies, today announced that Steven Kelly, President and Chief Executive Officer, will present at the JMP Securities Life Sciences Conference on Monday, May 15 at 1:00 pm EDT in New York.
Read more at prnewswire.comCarisma Therapeutics to Present at the JMP Securities Life Sciences Conference
PR Newswire - Press Release
All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here